开云app官网登录入口网页版-官方正版

#NCCN#

565篇内容 | 4689人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1320202, encodeId=3e78132020255, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=2022年NCCN指南解读：胃肠间质瘤, objectType=article, longId=737506, objectId=cf67e37506cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf67e37506cd, replyNumber=0, likeNumber=60, createdTime=2022-09-02, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf67e37506cd, moduleTitle=2022年NCCN指南解读：胃肠间质瘤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cf67e37506cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320201, encodeId=d27a13202018e, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=【今晚直播】2022年最新NCCN慢性粒细胞白血病指南要点解读, objectType=article, longId=737300, objectId=ec73e37300f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec73e37300f1, replyNumber=0, likeNumber=73, createdTime=2022-08-31, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec73e37300f1, moduleTitle=【今晚直播】2022年最新NCCN慢性粒细胞白血病指南要点解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ec73e37300f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320200, encodeId=bd50132020013, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=NCCN第三版非小细胞肺癌治疗指南出炉！国际前沿治疗局势一览, objectType=article, longId=735146, objectId=13bbe35146c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13bbe35146c3, replyNumber=0, likeNumber=103, createdTime=2022-08-09, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13bbe35146c3, moduleTitle=NCCN第三版非小细胞肺癌治疗指南出炉！国际前沿治疗局势一览, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=13bbe35146c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320198, encodeId=5ce11320198e1, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=NCCN发布首个儿童脑癌指南：强调基于NGS的变异分析在诊断、治疗等方面的重要性, objectType=article, longId=732693, objectId=e8dae3269300, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8dae3269300, replyNumber=0, likeNumber=132, createdTime=2022-07-20, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8dae3269300, moduleTitle=NCCN发布首个儿童脑癌指南：强调基于NGS的变异分析在诊断、治疗等方面的重要性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e8dae3269300)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320199, encodeId=cb281320199b9, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？, objectType=article, longId=731879, objectId=ad8de31879a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8de31879a3, replyNumber=0, likeNumber=110, createdTime=2022-07-11, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8de31879a3, moduleTitle=NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ad8de31879a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320197, encodeId=032c132019eea, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN：生活质量与胃癌患者的预后息息相关！, objectType=article, longId=300617, objectId=649d30061eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649d30061eba, replyNumber=0, likeNumber=102, createdTime=2022-03-14, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649d30061eba, moduleTitle=JNCCN：生活质量与胃癌患者的预后息息相关！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=649d30061eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320196, encodeId=bd30132019627, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN:左侧RAS/RAF野生型(WT) 转移性结直肠癌（mCRC）患者治疗策略趋势和预后, objectType=article, longId=299670, objectId=2fd12996e0f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd12996e0f7, replyNumber=0, likeNumber=104, createdTime=2022-02-27, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd12996e0f7, moduleTitle=JNCCN:左侧RAS/RAF野生型(WT) 转移性结直肠癌（mCRC）患者治疗策略趋势和预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2fd12996e0f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320195, encodeId=ee29132019547, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=NCCN丨非小细胞肺癌指南思维导图①（2021.7版）, objectType=article, longId=291896, objectId=473929189608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=473929189608, replyNumber=0, likeNumber=85, createdTime=2021-12-17, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=473929189608, moduleTitle=NCCN丨非小细胞肺癌指南思维导图①（2021.7版）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=473929189608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320194, encodeId=92051320194f9, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低, objectType=article, longId=217603, objectId=e41921e6037a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e41921e6037a, replyNumber=0, likeNumber=128, createdTime=2021-09-26, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e41921e6037a, moduleTitle=JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e41921e6037a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320193, encodeId=f70f132019342, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN：经肛门直肠全系膜切除术(TaTME) 治疗直肠癌的局部复发和无病生存期:来自国际TaTME注册研究的结果, objectType=article, longId=216818, objectId=d00f21681836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00f21681836, replyNumber=0, likeNumber=92, createdTime=2021-09-09, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00f21681836, moduleTitle=JNCCN：经肛门直肠全系膜切除术(TaTME) 治疗直肠癌的局部复发和无病生存期:来自国际TaTME注册研究的结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d00f21681836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320192, encodeId=1857132019208, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN：卡培他滨/替莫唑胺(CAPTEM)治疗神经内分泌肿瘤的疗效和安全性, objectType=article, longId=216808, objectId=6a23216808c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a23216808c1, replyNumber=0, likeNumber=0, createdTime=2021-09-09, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a23216808c1, moduleTitle=JNCCN：卡培他滨/替莫唑胺(CAPTEM)治疗神经内分泌肿瘤的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6a23216808c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320191, encodeId=3c6813201917a, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=NCCN：非手术治疗大肿块（5 -7 cm）、淋巴结阴性的非小细胞肺癌(NSCLC)患者大多不遵循NCCN指南治疗, objectType=article, longId=216800, objectId=78a021680015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a021680015, replyNumber=0, likeNumber=63, createdTime=2021-09-09, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a021680015, moduleTitle=NCCN：非手术治疗大肿块（5 -7 cm）、淋巴结阴性的非小细胞肺癌(NSCLC)患者大多不遵循NCCN指南治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=78a021680015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320190, encodeId=c4f81320190cb, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN：真实世界研究中转移性胰腺癌患者一线和二线治疗的预后, objectType=article, longId=216799, objectId=0e7f216e9991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e7f216e9991, replyNumber=0, likeNumber=81, createdTime=2021-09-09, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e7f216e9991, moduleTitle=JNCCN：真实世界研究中转移性胰腺癌患者一线和二线治疗的预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0e7f216e9991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320189, encodeId=de521320189a9, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN:肿瘤患者免疫检查点抑制剂相关口腔黏膜炎的临床特征和预后, objectType=article, longId=215394, objectId=feaa21539492, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feaa21539492, replyNumber=0, likeNumber=87, createdTime=2021-08-08, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feaa21539492, moduleTitle=JNCCN:肿瘤患者免疫检查点抑制剂相关口腔黏膜炎的临床特征和预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=feaa21539492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320188, encodeId=16e213201887b, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN:黑色素瘤患者出现肾上腺转移则对免疫检查点抑制剂耐药, objectType=article, longId=215390, objectId=5ac7215390be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ac7215390be, replyNumber=0, likeNumber=100, createdTime=2021-08-08, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ac7215390be, moduleTitle=JNCCN:黑色素瘤患者出现肾上腺转移则对免疫检查点抑制剂耐药, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5ac7215390be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320187, encodeId=5ba0132018e96, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=肺癌1b期目前nccn指南是化疗后靶向治疗奥希替尼，还是单存奥希替尼？, objectType=article, longId=215344, objectId=65042153449a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65042153449a, replyNumber=0, likeNumber=129, createdTime=2021-08-07, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65042153449a, moduleTitle=肺癌1b期目前nccn指南是化疗后靶向治疗奥希替尼，还是单存奥希替尼？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=65042153449a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320186, encodeId=a9461320186e6, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN：女性乳腺癌患者既往接受钼靶筛查对预后的影响, objectType=article, longId=215104, objectId=cf3e21510451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf3e21510451, replyNumber=0, likeNumber=83, createdTime=2021-08-02, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf3e21510451, moduleTitle=JNCCN：女性乳腺癌患者既往接受钼靶筛查对预后的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cf3e21510451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320185, encodeId=ba33132018581, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN：伴有前哨淋巴结（SN）阳性以及SN包膜结外延伸（ENE）的黑色素瘤患者的生存, objectType=article, longId=214994, objectId=c253214994bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c253214994bf, replyNumber=0, likeNumber=179, createdTime=2021-07-30, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c253214994bf, moduleTitle=JNCCN：伴有前哨淋巴结（SN）阳性以及SN包膜结外延伸（ENE）的黑色素瘤患者的生存, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c253214994bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320184, encodeId=6510132018471, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN:免疫治疗相关食管炎的临床特征、治疗反应和预后, objectType=article, longId=212682, objectId=594a212682ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=594a212682ae, replyNumber=0, likeNumber=0, createdTime=2021-06-15, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=594a212682ae, moduleTitle=JNCCN:免疫治疗相关食管炎的临床特征、治疗反应和预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=594a212682ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320183, encodeId=444113201830f, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, objectTitle=JNCCN:老年局部肛管癌患者放化疗的不同应用比较, objectType=article, longId=212609, objectId=9198212609a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9198212609a8, replyNumber=0, likeNumber=81, createdTime=2021-06-13, rootId=0, userName=旅苦化文_208, userId=e572480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9198212609a8, moduleTitle=JNCCN:老年局部肛管癌患者放化疗的不同应用比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9198212609a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

NCCN

2020-05-29

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

2022年NCCN指南解读：胃肠间质瘤

2022-09-02

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

【今晚直播】2022年最新NCCN慢性粒细胞白血病指南要点解读

2022-08-31

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

NCCN第三版非小细胞肺癌治疗指南出炉！国际前沿治疗局势一览

2022-08-09

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

NCCN发布首个儿童脑癌指南：强调基于NGS的变异分析在诊断、治疗等方面的重要性

2022-07-20

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？

2022-07-11

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN：生活质量与胃癌患者的预后息息相关！

2022-03-14

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN:左侧RAS/RAF野生型(WT) 转移性结直肠癌（mCRC）患者治疗策略趋势和预后

2022-02-27

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

NCCN丨非小细胞肺癌指南思维导图①（2021.7版）

2021-12-17

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低

2021-09-26

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN：经肛门直肠全系膜切除术(TaTME) 治疗直肠癌的局部复发和无病生存期:来自国际TaTME注册研究的结果

2021-09-09

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN：卡培他滨/替莫唑胺(CAPTEM)治疗神经内分泌肿瘤的疗效和安全性

2021-09-09

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

NCCN：非手术治疗大肿块（5 -7 cm）、淋巴结阴性的非小细胞肺癌(NSCLC)患者大多不遵循NCCN指南治疗

2021-09-09

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN：真实世界研究中转移性胰腺癌患者一线和二线治疗的预后

2021-09-09

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN:肿瘤患者免疫检查点抑制剂相关口腔黏膜炎的临床特征和预后

2021-08-08

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN:黑色素瘤患者出现肾上腺转移则对免疫检查点抑制剂耐药

2021-08-08

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

肺癌1b期目前nccn指南是化疗后靶向治疗奥希替尼，还是单存奥希替尼？

2021-08-07

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN：女性乳腺癌患者既往接受钼靶筛查对预后的影响

2021-08-02

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN：伴有前哨淋巴结（SN）阳性以及SN包膜结外延伸（ENE）的黑色素瘤患者的生存

2021-07-30

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN:免疫治疗相关食管炎的临床特征、治疗反应和预后

2021-06-15

旅苦化文_208 (审核中...)

前往app查看评论内容

#NCCN#

JNCCN:老年局部肛管癌患者放化疗的不同应用比较

2021-06-13

科室
- - 订阅+
  - 更多科室
工具
服务